Harmony Biosciences Holdings (HRMY) Receivables - Net (2019 - 2026)
Harmony Biosciences Holdings' Receivables - Net came in at $111 million for Q2 2026, up 19.4% from $92.98 million a year earlier and up 2.6% from the prior quarter.
Harmony Biosciences Holdings (HRMY) Receivables - Net (2019 - 2026) Analysis & Trends
At the end of FY2025, Harmony Biosciences Holdings' Receivables - Net was $96.79 million, up 16.6% from FY2024.
- Receivables - Net has increased in each of the last six years, with a five-year compound annual growth rate of 34.3% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $83.03 million in FY2024 (+12.0%), $74.14 million in FY2023 (+35.4%), $54.74 million in FY2022 (+57.1%) and $34.84 million in FY2021 (+57.1%).
- The Q2 2026 figure represents the highest quarterly Receivables - Net in data going back to Q4 2019.
- Year-over-year, Receivables - Net has increased for 20 consecutive quarters, with growth averaging 17.4% over the last eight quarters.
- The year-over-year growth in Receivables - Net has ranged between 2.1% (Q1 2026) and 103.4% (Q3 2021) over the last five years.
- Business Quant data shows HRMY's Receivables - Net at $108.22 million (Q1 2026), $96.79 million (Q4 2025) and $100.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.71 Bn | 1,136.29 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 647.75 Bn | 567.61 Bn | 17.30 Bn |
| 3 | AbbVie | 503.60 Bn | 476.71 Bn | 12.70 Bn |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.19 Bn | 267.18 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.04 Bn | 241.73 Bn | 12.86 Bn |
| 7 | Amgen | 242.69 Bn | 198.09 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.89 Bn | 169.09 Bn | 6.22 Bn |
| 9 | Pfizer | 173.31 Bn | 119.95 Bn | 10.94 Bn |
| 10 | Harmony Biosciences Holdings | 2.03 Bn | -724.89 Mn | 198.08 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111.00 Mn |
| Mar 31, 2026 | 108.22 Mn |
| Dec 31, 2025 | 96.79 Mn |
| Sep 30, 2025 | 100.65 Mn |
| Jun 30, 2025 | 92.98 Mn |
| Mar 31, 2025 | 105.97 Mn |
| Dec 31, 2024 | 83.03 Mn |
| Sep 30, 2024 | 81.50 Mn |
| Jun 30, 2024 | 83.16 Mn |
| Mar 31, 2024 | 79.72 Mn |
| Dec 31, 2023 | 74.14 Mn |
| Sep 30, 2023 | 67.26 Mn |
| Jun 30, 2023 | 63.81 Mn |
| Mar 31, 2023 | 52.58 Mn |
| Dec 31, 2022 | 54.74 Mn |
| Sep 30, 2022 | 55.07 Mn |
| Jun 30, 2022 | 49.82 Mn |
| Mar 31, 2022 | 38.13 Mn |
| Dec 31, 2021 | 34.84 Mn |
| Sep 30, 2021 | 33.21 Mn |
Harmony Biosciences Holdings Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=HRMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();